| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.094 | |
| circulatory system process | GO:0003013 | 197 | 0.078 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.074 | |
| renal system development | GO:0072001 | 225 | 0.069 | |
| angiogenesis | GO:0001525 | 201 | 0.066 | |
| muscle cell development | GO:0055001 | 133 | 0.064 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.061 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.057 | |
| extracellular structure organization | GO:0043062 | 148 | 0.057 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.056 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.055 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.055 | |
| regulation of system process | GO:0044057 | 200 | 0.053 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.053 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.052 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.048 | |
| muscle tissue development | GO:0060537 | 308 | 0.047 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.045 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.044 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.043 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.042 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.040 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.038 | |
| response to growth factor | GO:0070848 | 198 | 0.038 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.038 | |
| muscle system process | GO:0003012 | 141 | 0.038 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.038 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.037 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.037 | |
| connective tissue development | GO:0061448 | 179 | 0.037 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.036 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.036 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.036 | |
| striated muscle cell development | GO:0055002 | 125 | 0.036 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.035 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.035 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.035 | |
| response to amino acid | GO:0043200 | 37 | 0.034 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.034 | |
| heart morphogenesis | GO:0003007 | 178 | 0.033 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.032 | |
| oxidation reduction process | GO:0055114 | 342 | 0.032 | |
| urogenital system development | GO:0001655 | 261 | 0.031 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.031 | |
| calcium ion transport | GO:0006816 | 159 | 0.031 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.031 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.031 | |
| skeletal system development | GO:0001501 | 356 | 0.030 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.030 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.030 | |
| respiratory system development | GO:0060541 | 190 | 0.029 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.029 | |
| stem cell differentiation | GO:0048863 | 268 | 0.029 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.028 | |
| physiological cardiac muscle hypertrophy | GO:0003301 | 3 | 0.028 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 26 | 0.028 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.027 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.027 | |
| organ growth | GO:0035265 | 117 | 0.027 | |
| drug metabolic process | GO:0017144 | 4 | 0.027 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.026 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.026 | |
| respiratory tube development | GO:0030323 | 167 | 0.026 | |
| mesenchyme development | GO:0060485 | 152 | 0.026 | |
| regulation of heart growth | GO:0060420 | 31 | 0.026 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.025 | |
| epithelium migration | GO:0090132 | 63 | 0.025 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.025 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.025 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.024 | |
| cell growth involved in cardiac muscle cell development | GO:0061049 | 3 | 0.024 | |
| vascular endothelial growth factor receptor signaling pathway | GO:0048010 | 24 | 0.024 | |
| cation transport | GO:0006812 | 399 | 0.024 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.023 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.023 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.023 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.023 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.023 | |
| tissue remodeling | GO:0048771 | 102 | 0.023 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.023 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.023 | |
| cytokine production | GO:0001816 | 319 | 0.023 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.022 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.022 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.022 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.022 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.022 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.021 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.021 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.021 | |
| blood circulation | GO:0008015 | 195 | 0.021 | |
| lung development | GO:0030324 | 164 | 0.021 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.021 | |
| negative regulation of growth | GO:0045926 | 99 | 0.021 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.021 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.021 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.020 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.020 | |
| cartilage development | GO:0051216 | 140 | 0.020 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.020 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.020 | |
| muscle contraction | GO:0006936 | 101 | 0.020 | |
| digestive system development | GO:0055123 | 200 | 0.020 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.020 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.020 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.020 | |
| forebrain development | GO:0030900 | 302 | 0.019 | |
| placenta development | GO:0001890 | 140 | 0.019 | |
| tissue homeostasis | GO:0001894 | 115 | 0.019 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.019 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.019 | |
| hindbrain development | GO:0030902 | 128 | 0.019 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.019 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.019 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.019 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.019 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.018 | |
| drug catabolic process | GO:0042737 | 2 | 0.018 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.018 | |
| camera type eye development | GO:0043010 | 266 | 0.018 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.018 | |
| kidney development | GO:0001822 | 213 | 0.018 | |
| regulation of ossification | GO:0030278 | 112 | 0.018 | |
| compound eye development | GO:0048749 | 1 | 0.018 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.018 | |
| regulation of cell growth involved in cardiac muscle cell development | GO:0061050 | 3 | 0.018 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.018 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.017 | |
| endochondral bone growth | GO:0003416 | 19 | 0.017 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.017 | |
| tissue migration | GO:0090130 | 68 | 0.017 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.017 | |
| physiological muscle hypertrophy | GO:0003298 | 3 | 0.017 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.017 | |
| inflammatory response | GO:0006954 | 244 | 0.017 | |
| organelle localization | GO:0051640 | 179 | 0.017 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.017 | |
| bone development | GO:0060348 | 120 | 0.017 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.017 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.017 | |
| cell adhesion | GO:0007155 | 329 | 0.017 | |
| spinal cord development | GO:0021510 | 81 | 0.017 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.017 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.016 | |
| regulation of cell growth | GO:0001558 | 91 | 0.016 | |
| regulation of tooth mineralization | GO:0070170 | 2 | 0.016 | |
| regionalization | GO:0003002 | 337 | 0.016 | |
| muscle fiber development | GO:0048747 | 76 | 0.016 | |
| transmembrane transport | GO:0055085 | 412 | 0.016 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.016 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.016 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.016 | |
| response to acid chemical | GO:0001101 | 111 | 0.016 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.016 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.016 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.016 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.016 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.016 | |
| amine metabolic process | GO:0009308 | 45 | 0.016 | |
| regulation of organ growth | GO:0046620 | 61 | 0.016 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.016 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.016 | |
| synaptic transmission | GO:0007268 | 329 | 0.016 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.016 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.015 | |
| neuromuscular process | GO:0050905 | 99 | 0.015 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.015 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.015 | |
| biomineral tissue development | GO:0031214 | 64 | 0.015 | |
| regulation of androgen receptor signaling pathway | GO:0060765 | 3 | 0.015 | |
| regulation of white fat cell proliferation | GO:0070350 | 2 | 0.015 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.015 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.015 | |
| neural tube formation | GO:0001841 | 108 | 0.015 | |
| epithelial tube formation | GO:0072175 | 130 | 0.015 | |
| aminoglycan metabolic process | GO:0006022 | 34 | 0.015 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.015 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.015 | |
| positive regulation of transcription from rna polymerase i promoter | GO:0045943 | 3 | 0.015 | |
| heart growth | GO:0060419 | 45 | 0.014 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.014 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.014 | |
| elastic fiber assembly | GO:0048251 | 4 | 0.014 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.014 | |
| ossification | GO:0001503 | 216 | 0.014 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.014 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.014 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.014 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.014 | |
| negative regulation of hormone metabolic process | GO:0032351 | 4 | 0.014 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.014 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.014 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.014 | |
| regulation of cell activation | GO:0050865 | 289 | 0.014 | |
| regulation of protein binding | GO:0043393 | 60 | 0.014 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.014 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.013 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.013 | |
| tube closure | GO:0060606 | 91 | 0.013 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.013 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.013 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.013 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.013 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.013 | |
| chondroitin sulfate proteoglycan metabolic process | GO:0050654 | 20 | 0.013 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.013 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.013 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.013 | |
| muscle adaptation | GO:0043500 | 39 | 0.013 | |
| multi organism behavior | GO:0051705 | 62 | 0.013 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.013 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.013 | |
| rhythmic process | GO:0048511 | 174 | 0.013 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.013 | |
| detection of chemical stimulus involved in sensory perception of smell | GO:0050911 | 4 | 0.013 | |
| protein localization to membrane | GO:0072657 | 108 | 0.013 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.013 | |
| stem cell development | GO:0048864 | 219 | 0.013 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.013 | |
| regulation of odontogenesis | GO:0042481 | 18 | 0.012 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.012 | |
| olfactory lobe development | GO:0021988 | 32 | 0.012 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.012 | |
| dorsal ventral axon guidance | GO:0033563 | 3 | 0.012 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.012 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 33 | 0.012 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.012 | |
| cardiac cell development | GO:0055006 | 41 | 0.012 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.012 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.012 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.012 | |
| mesonephros development | GO:0001823 | 97 | 0.012 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.012 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.012 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.012 | |
| primary neural tube formation | GO:0014020 | 95 | 0.012 | |
| notch signaling pathway | GO:0007219 | 71 | 0.012 | |
| neural tube development | GO:0021915 | 160 | 0.012 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.012 | |
| cellular homeostasis | GO:0019725 | 240 | 0.012 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.012 | |
| immune effector process | GO:0002252 | 321 | 0.012 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.012 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.012 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.012 | |
| mucopolysaccharide metabolic process | GO:1903510 | 25 | 0.012 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.012 | |
| male anatomical structure morphogenesis | GO:0090598 | 4 | 0.012 | |
| spermatogenesis | GO:0007283 | 284 | 0.012 | |
| negative regulation of cell proliferation involved in contact inhibition | GO:0060244 | 3 | 0.012 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.011 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.011 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.011 | |
| endomembrane system organization | GO:0010256 | 147 | 0.011 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.011 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.011 | |
| olfactory bulb development | GO:0021772 | 30 | 0.011 | |
| bone morphogenesis | GO:0060349 | 78 | 0.011 | |
| regulation of binding | GO:0051098 | 111 | 0.011 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.011 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.011 | |
| embryonic placenta development | GO:0001892 | 98 | 0.011 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.011 | |
| body fluid secretion | GO:0007589 | 53 | 0.011 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.011 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.011 | |
| heart process | GO:0003015 | 94 | 0.011 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.011 | |
| lung alveolus development | GO:0048286 | 45 | 0.011 | |
| ear morphogenesis | GO:0042471 | 118 | 0.011 | |
| locomotory behavior | GO:0007626 | 195 | 0.011 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.011 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.011 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.011 | |
| response to oxidative stress | GO:0006979 | 123 | 0.011 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.011 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.011 | |
| mesenchymal cell proliferation | GO:0010463 | 44 | 0.011 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.011 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.011 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.011 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.011 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.011 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.011 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.011 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.011 | |
| neuron migration | GO:0001764 | 122 | 0.011 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.011 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.011 | |
| naphthalene containing compound metabolic process | GO:0090420 | 1 | 0.011 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.011 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.011 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.011 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.011 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.011 | |
| endocrine system development | GO:0035270 | 98 | 0.011 | |
| submandibular salivary gland formation | GO:0060661 | 1 | 0.011 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.011 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.011 | |
| ear development | GO:0043583 | 200 | 0.011 | |
| cell growth | GO:0016049 | 130 | 0.011 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.011 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.011 | |
| regulation of macrophage migration inhibitory factor signaling pathway | GO:2000446 | 1 | 0.011 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.011 | |
| cellular glucan metabolic process | GO:0006073 | 32 | 0.010 | |
| protein maturation | GO:0051604 | 176 | 0.010 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.010 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.010 | |
| spermatid development | GO:0007286 | 108 | 0.010 | |
| mesoderm development | GO:0007498 | 100 | 0.010 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.010 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.010 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.010 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.010 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.010 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.010 | |